Scott Simon Tykodi MD PhD

Associate Professor, Division of Medical Oncology, University of Washington Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center

Join to view full profile

Seattle Cancer Care Alliance825 Eastlake Avenue, ESeattle, WA 98109
Phone+1 206-606-2015

Dr. Tykodi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tykodi's full profile Already have an account?

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 2000 - 2003
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1997 - 2000
WashU MedicineClass of 1997

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

WA State Medical License 2000 - 2027
American Board of Internal Medicine Medical Oncology

Clinical Trials

Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer Start of enrollment: 2018 Aug 28
TERMINATED
PHASE1

Publications & Presentations

PubMed

Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases: A Case-Based Radiosurgery Society Review.
Yilan Liu, Naomi Goldrich, Kristin J Redmond, Jonathan Gabriel, Nancy Zhou
Practical Radiation Oncology. 2026-04-18
Case Report: donor cell-derived leukemia after allogeneic stem cell transplantation for metastatic renal cell carcinoma.
Federico Monaco, Danh T Tran, Brenda M Sandmaier, Scott S Tykodi
Frontiers in Immunology. 2026-01-01
From surgery to systemic therapy in von Hippel-Lindau disease: insights from extended follow-up of LITESPARK-004.
Lisa M Tachiki, Scott S Tykodi
Translational Andrology and Urology. 2025-11-30

Lectures

First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated results for KEYNOTE-427 cohort A.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

ASCO GU 2021: Nivolumab plus Ipilimumab in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma (nccRCC): Safety and Efficacy from CheckMate 920February 13th, 2021
Vaccinia Virus and Immune Checkpoint Inhibitors: A Viable Combination in Advanced RCC?May 27th, 2020
ASCO Annual Meeting to Highlight Clinical Oncology Findings from Seattle Cancer Care Alliance (SCCA)May 21st, 2020